Literature DB >> 9584176

Cloning and characterization of a specific receptor for mouse oncostatin M.

R A Lindberg1, T S Juan, A A Welcher, Y Sun, R Cupples, B Guthrie, F A Fletcher.   

Abstract

Oncostatin M (OSM) is a member of a family of cytokines that includes ciliary neurotrophic factor, interleukin-6, interleukin-11, cardiotrophin-1, and leukemia inhibitory factor (LIF). The receptors for these cytokines consist of a common signaling subunit, gp130, to which other subunits are added to modify ligand specificity. We report here the isolation and characterization of a cDNA encoding a subunit of the mouse OSM receptor. In NIH 3T3 cells (which endogenously express gp130, LIF receptor beta [LIFRbeta], and the protein product, c12, of the cDNA described here), mouse LIF, human LIF, and human OSM signaled through receptors containing the LIFRbeta and gp130 but not through the mouse OSM receptor. Mouse OSM, however, signaled only through a c12-gp130 complex; it did not use the LIF receptor. Binding studies demonstrated that mouse OSM associated directly with either the c12 protein or gp130. These data highlight the species-specific differences in receptor utilization and signal transduction between mouse and human OSM. In mouse cells, only mouse OSM is capable of activating the mouse OSM receptor; human OSM instead activates the LIF receptor. Therefore, these data suggest that all previous studies with human OSM in mouse systems did not elucidate the biology of OSM but, rather, reflected the biological actions of LIF.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9584176      PMCID: PMC108917          DOI: 10.1128/MCB.18.6.3357

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  19 in total

1.  The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor.

Authors:  D P Gearing; M R Comeau; D J Friend; S D Gimpel; C J Thut; J McGourty; K K Brasher; J A King; S Gillis; B Mosley
Journal:  Science       Date:  1992-03-13       Impact factor: 47.728

2.  Oncostatin M and leukemia inhibitory factor do not use the same functional receptor in mice.

Authors:  M Ichihara; T Hara; H Kim; T Murate; A Miyajima
Journal:  Blood       Date:  1997-07-01       Impact factor: 22.113

3.  Molecular cloning and expression of an IL-6 signal transducer, gp130.

Authors:  M Hibi; M Murakami; M Saito; T Hirano; T Taga; T Kishimoto
Journal:  Cell       Date:  1990-12-21       Impact factor: 41.582

4.  Critical cytoplasmic region of the interleukin 6 signal transducer gp130 is conserved in the cytokine receptor family.

Authors:  M Murakami; M Narazaki; M Hibi; H Yawata; K Yasukawa; M Hamaguchi; T Taga; T Kishimoto
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

5.  High-efficiency transformation of mammalian cells by plasmid DNA.

Authors:  C Chen; H Okayama
Journal:  Mol Cell Biol       Date:  1987-08       Impact factor: 4.272

6.  Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation.

Authors:  B Mosley; C De Imus; D Friend; N Boiani; B Thoma; L S Park; D Cosman
Journal:  J Biol Chem       Date:  1996-12-20       Impact factor: 5.157

7.  Nerve growth factor binding domain of the nerve growth factor receptor.

Authors:  A A Welcher; C M Bitler; M J Radeke; E M Shooter
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-01       Impact factor: 11.205

8.  Cardiotrophin-1. Biological activities and binding to the leukemia inhibitory factor receptor/gp130 signaling complex.

Authors:  D Pennica; K J Shaw; T A Swanson; M W Moore; D L Shelton; K A Zioncheck; A Rosenthal; T Taga; N F Paoni; W I Wood
Journal:  J Biol Chem       Date:  1995-05-05       Impact factor: 5.157

9.  Mouse oncostatin M: an immediate early gene induced by multiple cytokines through the JAK-STAT5 pathway.

Authors:  A Yoshimura; M Ichihara; I Kinjyo; M Moriyama; N G Copeland; D J Gilbert; N A Jenkins; T Hara; A Miyajima
Journal:  EMBO J       Date:  1996-03-01       Impact factor: 11.598

10.  Leukemia inhibitory factor receptor is structurally related to the IL-6 signal transducer, gp130.

Authors:  D P Gearing; C J Thut; T VandeBos; S D Gimpel; P B Delaney; J King; V Price; D Cosman; M P Beckmann
Journal:  EMBO J       Date:  1991-10       Impact factor: 11.598

View more
  32 in total

Review 1.  Receptor recognition by gp130 cytokines.

Authors:  J Bravo; J K Heath
Journal:  EMBO J       Date:  2000-06-01       Impact factor: 11.598

2.  K-Ras mediates cytokine-induced formation of E-cadherin-based adherens junctions during liver development.

Authors:  Takaaki Matsui; Taisei Kinoshita; Yoshihiro Morikawa; Kazuo Tohya; Motoya Katsuki; Yoshiaki Ito; Akihide Kamiya; Atsushi Miyajima
Journal:  EMBO J       Date:  2002-03-01       Impact factor: 11.598

3.  Murine oncostatin M stimulates mouse synovial fibroblasts in vitro and induces inflammation and destruction in mouse joints in vivo.

Authors:  C Langdon; C Kerr; M Hassen; T Hara; A L Arsenault; C D Richards
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

4.  Fetal liver development requires a paracrine action of oncostatin M through the gp130 signal transducer.

Authors:  A Kamiya; T Kinoshita; Y Ito; T Matsui; Y Morikawa; E Senba; K Nakashima; T Taga; K Yoshida; T Kishimoto; A Miyajima
Journal:  EMBO J       Date:  1999-04-15       Impact factor: 11.598

5.  Oncostatin M is a potential agent for the treatment of obesity and related metabolic disorders: a study in mice.

Authors:  Tadasuke Komori; Minoru Tanaka; Hiroto Furuta; Takashi Akamizu; Atsushi Miyajima; Yoshihiro Morikawa
Journal:  Diabetologia       Date:  2015-05-14       Impact factor: 10.122

Review 6.  The role of the leukemia inhibitory factor receptor in neuroprotective signaling.

Authors:  Stephanie M Davis; Keith R Pennypacker
Journal:  Pharmacol Ther       Date:  2017-08-19       Impact factor: 12.310

7.  Adenoviral transfer of murine oncostatin M elicits periosteal bone apposition in knee joints of mice, despite synovial inflammation and up-regulated expression of interleukin-6 and receptor activator of nuclear factor-kappa B ligand.

Authors:  Alfons S K de Hooge; Fons A J van de Loo; Miranda B Bennink; Diana S de Jong; Onno J Arntz; Erik Lubberts; Carl D Richards; Wim B vandDen Berg
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

8.  Temporal expression of mRNAs for neuropoietic cytokines, interleukin-11 (IL-11), oncostatin M (OSM), cardiotrophin-1 (CT-1) and their receptors (IL-11Ralpha and OSMRbeta) in peripheral nerve injury.

Authors:  Y Ito; M Yamamoto; M Li; N Mitsuma; F Tanaka; M Doyu; A Suzumura; T Mitsuma; G Sobue
Journal:  Neurochem Res       Date:  2000-08       Impact factor: 3.996

9.  Oncostatin M and its role in fibrosis.

Authors:  Lukasz Stawski; Maria Trojanowska
Journal:  Connect Tissue Res       Date:  2018-07-30       Impact factor: 3.417

10.  Murine Oncostatin M Acts via Leukemia Inhibitory Factor Receptor to Phosphorylate Signal Transducer and Activator of Transcription 3 (STAT3) but Not STAT1, an Effect That Protects Bone Mass.

Authors:  Emma C Walker; Rachelle W Johnson; Yifang Hu; Holly J Brennan; Ingrid J Poulton; Jian-Guo Zhang; Brendan J Jenkins; Gordon K Smyth; Nicos A Nicola; Natalie A Sims
Journal:  J Biol Chem       Date:  2016-08-18       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.